Morningstar Acciones

平安健康医疗科技有限公司 01833 StarRatingValueLabel_3Mr. Lee Davidson, Head of Quantitative Research

Último Precio
11,04
Cambio del día
0,56|5,34%

a 26/04/2024
16:08:19 HKT | HKD  Minimum 15 Minutes Delay.

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
11,04 - 11,0610,48 - 11,1211.199.1625.954.80212,35Bil
Último Cierre52 Week RangeP/BeneficioDividendo %ISIN
10,489,63 - 21,55--KYG711391022

Cotización Ping An Healthcare And Technology Co Ltd

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
More...
Cuenta de Resultados
Ingresos7.334,216.159,824.673,56
Operating Income-1.829,58-1.087,21-697,86
Resultado Neto-1.538,18-607,57-322,59
Beneficio Básico por Acción-1,39-0,56-0,30
Num Medio Acciones diluidas en circulación1.1031.0811.080
Balance
Activo Corriente12.757,1312.463,7313.327,40
Activos no corrientes5.123,564.678,343.192,64
Total Activo 17.880,6917.142,0716.520,04
Pasivo corriente3.673,853.482,923.097,08
Total Pasivo---
Total Equity14.083,4213.459,5813.283,63
Flujo de Caja
Flujo de caja operativo-1.403,00-810,62-282,86
Inversiones de Capital-89,15-34,44-42,96
Flujo de Caja Libre-1.492,15-845,05-325,82

En millones, excepto "EPS básico". Currency is CNY.

Perfil de la compañía

Ping An Healthcare and Technology is the parent of Ping An Good Doctor, or PAGD, an online platform offering healthcare services in the form of a health maintenance organization, or HMO, model that provides commercial healthcare services and offers healthcare checkup, healthcare management, and corporate reimbursement for a fee. The company leverages the network of health providers from its parent Ping An Group, where it enters into contracts with physicians, hospitals, and specialists to offer their services to HMO participants. Other than commercial healthcare premium services, PAGD offers online consultations and prescription e-commerce online to individuals. The platform has 978 corporate clients and 43 million paying users. PAGD is 38.43% owned by its parent company.

Sector

Atención sanitaria

Industria

Servicios de Información Sanitaria

Estilo de acciones

Media-Valor

Fin Ejercicio Fiscal

diciembre

Empleados

1.753
Datos destacados
More...
Precio/Beneficio 12 m-
Precio/Valor contable0,82
Price/Sales TTM-
Crec Ingresos (media 3 a)-12,03
Crec BPA (media 3 a)-
Margen operativo-14,93
Margen neto-6,90
ROE 12 m-2,41
Deuda/Fondos propios0,00
Dividendos
AntLatest
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0,000,00
Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. Reservados todos los derechos.

Términos de uso        Política Privacidad        Cookie Settings        Aviso Legal